Northern Trust
JANX icon

Northern Trust’s Janux Therapeutics JANX Stock Holding History

Northern Trust’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.12M Buy
398,366
+36,186
+10% +$524K ﹤0.01% 2511
2026
Q1 		$5.03M Buy
362,180
+21,774
+6% +$299K ﹤0.01% 2453
2025
Q4 		$4.7M Sell
340,406
-13,707
-4% -$322K ﹤0.01% 2508
2025
Q3 		$8.65M Buy
354,113
+12,271
+4% +$299K ﹤0.01% 2195
2025
Q2 		$7.9M Buy
341,842
+42,623
+14% +$1.12M ﹤0.01% 2205
2025
Q1 		$8.08M Sell
299,219
-9,581
-3% -$361K ﹤0.01% 2167
2024
Q4 		$16.5M Buy
308,800
+42,302
+16% +$2.24M ﹤0.01% 1817
2024
Q3 		$12.1M Buy
266,498
+72,125
+37% +$3.14M ﹤0.01% 1958
2024
Q2 		$8.14M Sell
194,373
-7,610
-4% -$357K ﹤0.01% 2106
2024
Q1 		$7.6M Sell
201,983
-2,019
-1% -$44K ﹤0.01% 2220
2023
Q4 		$2.19M Buy
204,002
+11,317
+6% +$97.9K ﹤0.01% 2950
2023
Q3 		$1.94M Buy
192,685
+5,395
+3% +$62.2K ﹤0.01% 2960
2023
Q2 		$2.22M Buy
187,290
+47,319
+34% +$632K ﹤0.01% 2952
2023
Q1 		$1.69M Buy
139,971
+243
+0.2% +$4.04K ﹤0.01% 3006
2022
Q4 		$1.84M Buy
139,728
+3,364
+2% +$49.2K ﹤0.01% 3047
2022
Q3 		$1.85M Buy
136,364
+3,207
+2% +$42.8K ﹤0.01% 3048
2022
Q2 		$1.63M Sell
133,157
-7,090
-5% -$83.9K ﹤0.01% 3168
2022
Q1 		$2.01M Buy
140,247
+24,752
+21% +$405K ﹤0.01% 3103
2021
Q4 		$2.28M Sell
115,495
-1,466
-1% -$30.7K ﹤0.01% 3161
2021
Q3 		$2.53M Buy
+116,961
New +$3.37M ﹤0.01% 3150

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Northern Trust's JANX Position: Q2 2026 in Review

Northern Trust increased its Janux Therapeutics (JANX) stake by 10% in Q2 2026, buying an estimated $524K and bringing the position to 398,366 shares worth $6.12M. The position accounts for ﹤0.01% of the portfolio, ranked #2511.

Northern Trust first reported a position in JANX in Q3 2021 and has held it in 20 quarters since. The position peaked at $16.5M in Q4 2024. 197 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • Northern Trust held 398,366 shares of Janux Therapeutics worth $6.12M as of Q2 2026.
  • Northern Trust bought 36,186 Janux Therapeutics shares in Q2 2026, an estimated $524K.
  • Janux Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #2511 holding.
  • Northern Trust first reported a position in Janux Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • Northern Trust's Janux Therapeutics position peaked at $16.5M in Q4 2024.
  • 197 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.